| 000 | 01768 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250516003706.0 | ||
| 264 | 0 | _c20110309 | |
| 008 | 201103s 0 0 eng d | ||
| 022 | _a1873-3476 | ||
| 024 | 7 |
_a10.1016/j.ijpharm.2010.09.015 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTanaka, T | |
| 245 | 0 | 0 |
_aIn vivo evaluation of safety of nanoporous silicon carriers following single and multiple dose intravenous administrations in mice. _h[electronic resource] |
| 260 |
_bInternational journal of pharmaceutics _cDec 2010 |
||
| 300 |
_a190-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCytokines _xblood |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 |
_aDrug Carriers _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Delivery Systems |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aInjections, Intravenous |
| 650 | 0 | 4 |
_aL-Lactate Dehydrogenase _xmetabolism |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMicrospheres |
| 650 | 0 | 4 | _aNanopores |
| 650 | 0 | 4 |
_aSilicon _xadministration & dosage |
| 650 | 0 | 4 | _aToxicity Tests |
| 700 | 1 | _aGodin, B | |
| 700 | 1 | _aBhavane, R | |
| 700 | 1 | _aNieves-Alicea, R | |
| 700 | 1 | _aGu, J | |
| 700 | 1 | _aLiu, X | |
| 700 | 1 | _aChiappini, C | |
| 700 | 1 | _aFakhoury, J R | |
| 700 | 1 | _aAmra, S | |
| 700 | 1 | _aEwing, A | |
| 700 | 1 | _aLi, Q | |
| 700 | 1 | _aFidler, I J | |
| 700 | 1 | _aFerrari, M | |
| 773 | 0 |
_tInternational journal of pharmaceutics _gvol. 402 _gno. 1-2 _gp. 190-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ijpharm.2010.09.015 _zAvailable from publisher's website |
| 999 |
_c20211979 _d20211979 |
||